{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:22:32Z","timestamp":1787030552184,"version":"build-2736575974"},"reference-count":33,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2022.13550","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T02:14:55Z","timestamp":1666145695000},"source":"Crossref","is-referenced-by-count":10,"title":["Primary vaginal malignant melanoma successfully treated with combination therapy: A case report"],"prefix":"10.3892","volume":"24","author":[{"given":"Ping","family":"Yin","sequence":"first","affiliation":[{"name":"School of Clinical Medicine, Weifang Medical University, Weifang, Shandong 261053, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Oncology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong 261041, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Jinming Yu Academician Workstation of Oncology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong 261041, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Song","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Weifang Medical University, Weifang, Shandong 261053, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Weifang Medical University, Weifang, Shandong 261053, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Lu","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Weifang Medical University, Weifang, Shandong 261053, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2022,10,19]]},"reference":[{"key":"key20221123122139_b1-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.4103\/jcrt.JCRT_893_15","article-title":"Primary vaginal malignant melanoma: A rare entity with review of literature","volume":"15","author":"Puri","year":"2019","journal-title":"J Cancer Res Ther"},{"key":"key20221123122139_b2-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1634\/theoncologist.2019-0148","article-title":"Prevalence of NRAS mutation, PD-L1 expression and amplification, and overall survival analysis in 36 primary vaginal melanomas","volume":"25","author":"Wang","year":"2020","journal-title":"Oncologist"},{"key":"key20221123122139_b3-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1097\/00000478-200211000-00007","article-title":"Vaginal melanoma: A clinicopathologic and immunohistochemical study of 26 cases","volume":"26","author":"Gupta","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"key20221123122139_b4-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S1470-2045(08)70254-7","article-title":"Management of primary melanoma of the female urogenital tract","volume":"9","author":"Piura","year":"2008","journal-title":"Lancet Oncol"},{"key":"key20221123122139_b5-ol-24-06-13550","first-page":"122","article-title":"Vaginal primary malignant melanoma: Report of four cases and review of the literature","volume":"32","author":"Terzakis","year":"2011","journal-title":"Eur J Gynaecol Oncol"},{"key":"key20221123122139_b6-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"e25691","DOI":"10.1097\/MD.0000000000025691","article-title":"Primary vaginal malignant melanoma: A rare case report of successful treatment with nivolumab","volume":"100","author":"Guo","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"key20221123122139_b7-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1097\/AOG.0b013e3181fb8045","article-title":"Primary malignant melanoma of the vagina","volume":"116","author":"Frumovitz","year":"2010","journal-title":"Obstet Gynecol"},{"key":"key20221123122139_b8-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"9324","DOI":"10.3390\/ijms21239324","article-title":"Immunostimulatory effects of radiotherapy for local and systemic control of melanoma: A review","volume":"21","author":"Takahashi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"key20221123122139_b9-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","article-title":"Enhancing cancer immunotherapy using antiangiogenics: Opportunities and challenges","volume":"15","author":"Fukumura","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"key20221123122139_b10-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"300","DOI":"10.21037\/tau-20-969","article-title":"Efficacy and safety of immunological checkpoint inhibitors combined with anti-angiogenic drugs in first-line treatment of metastatic renal cell carcinoma: A systematic review and meta-analysis","volume":"10","author":"Xie","year":"2021","journal-title":"Transl Androl Urol"},{"key":"key20221123122139_b11-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s12276-020-00500-y","article-title":"Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity","volume":"52","author":"Lee","year":"2020","journal-title":"Exp Mol Med"},{"key":"key20221123122139_b12-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.3389\/fimmu.2018.03107","article-title":"Combining radiotherapy with anti-angiogenic therapy and immunotherapy; a therapeutic triad for cancer?","volume":"9","author":"Goedegebuure","year":"2019","journal-title":"Front Immunol"},{"key":"key20221123122139_b13-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"598877","DOI":"10.3389\/fimmu.2020.598877","article-title":"Augmenting anticancer immunity through combined targeting of angiogenic and PD-1\/PD-L1 pathways: Challenges and opportunities","volume":"11","author":"Hack","year":"2020","journal-title":"Front Immunol"},{"key":"key20221123122139_b14-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13045-018-0693-2","article-title":"Safety and clinical activity with an anti-PD-1 antibody JS001 in advanced melanoma or urologic cancer patients","volume":"12","author":"Tang","year":"2019","journal-title":"J Hematol Oncol"},{"key":"key20221123122139_b15-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-018-0647-8","article-title":"Abscopal effect of radiotherapy combined with immune checkpoint inhibitors","volume":"11","author":"Liu","year":"2018","journal-title":"J Hematol Oncol"},{"key":"key20221123122139_b16-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.3390\/cancers12102762","article-title":"Radiotherapy-mediated immunomodulation and anti-tumor abscopal effect combining immune checkpoint blockade","volume":"12","author":"Zhao","year":"2020","journal-title":"Cancers (Basel)"},{"key":"key20221123122139_b17-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrc.2018.6","article-title":"Using immunotherapy to boost the abscopal effect","volume":"18","author":"Ngwa","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"key20221123122139_b18-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ijrobp.2012.03.017","article-title":"The abscopal effect associated with a systemic anti-melanoma immune response","volume":"85","author":"Stamell","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20221123122139_b19-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"9435389","DOI":"10.1155\/2019\/9435389","article-title":"Radiotherapy for melanoma: More than DNA damage","volume":"2019","author":"Rogers","year":"2019","journal-title":"Dermatol Res Pract"},{"key":"key20221123122139_b20-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13014-020-01615-2","article-title":"Radiotherapy for lentigo maligna and lentigo maligna melanoma-a systematic review","volume":"15","author":"Hendrickx","year":"2020","journal-title":"Radiat Oncol"},{"key":"key20221123122139_b21-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1089\/cbr.2012.1202","article-title":"Abscopal regression of antigen disparate tumors by antigen cascade after systemic tumor vaccination in combination with local tumor radiation","volume":"27","author":"Hodge","year":"2012","journal-title":"Cancer Biother Radiopharm"},{"key":"key20221123122139_b22-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1158\/1078-0432.728.11.2","article-title":"Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer","volume":"11","author":"Demaria","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20221123122139_b23-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fonc.2014.00325","article-title":"Combinations of immunotherapy and radiation in cancer therapy","volume":"4","author":"Vatner","year":"2014","journal-title":"Front Oncol"},{"key":"key20221123122139_b24-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"key":"key20221123122139_b25-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1016\/j.jtho.2017.04.029","article-title":"Radiotherapy rescue of a nivolumab-refractory immune response in a patient with PD-L1-negative metastatic squamous cell carcinoma of the lung","volume":"12","author":"Yuan","year":"2017","journal-title":"J Thorac Oncol"},{"key":"key20221123122139_b26-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/j.jtho.2017.05.004","article-title":"Abscopal effect of nivolumab in a patient with primary lung cancer","volume":"12","author":"Komatsu","year":"2017","journal-title":"J Thorac Oncol"},{"key":"key20221123122139_b27-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ejca.2021.08.034","article-title":"Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter study","volume":"157","author":"Umeda","year":"2021","journal-title":"Eur J Cancer"},{"key":"key20221123122139_b28-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ctro.2017.12.004","article-title":"Combining radiotherapy and ipilimumab induces clinically relevant radiation-induced abscopal effects in metastatic melanoma patients: A systematic review","volume":"9","author":"Chicas-Sett","year":"2017","journal-title":"Clin Transl Radiat Oncol"},{"key":"key20221123122139_b29-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00262-019-02351-7","article-title":"Evaluation of the efficacy of immunotherapy for non-resectable mucosal melanoma","volume":"68","author":"Moya-Plana","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"key20221123122139_b30-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.3802\/jgo.2019.30.e94","article-title":"Investigating the role of immunotherapy in advanced\/recurrent female genital tract melanoma: A preliminary experience","volume":"30","author":"Indini","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"key20221123122139_b31-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ctrv.2015.03.011","article-title":"The abscopal effect of local radiotherapy: Using immunotherapy to make a rare event clinically relevant","volume":"41","author":"Reynders","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"key20221123122139_b32-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1172\/JCI67313","article-title":"Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice","volume":"124","author":"Deng","year":"2014","journal-title":"J Clin Invest"},{"key":"key20221123122139_b33-ol-24-06-13550","doi-asserted-by":"publisher","first-page":"111607","DOI":"10.1016\/j.biopha.2021.111607","article-title":"Vascular normalization in immunotherapy: A promising mechanisms combined with radiotherapy","volume":"139","author":"Liu","year":"2021","journal-title":"Biomed Pharmacother"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T05:25:24Z","timestamp":1669181124000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2022.13550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,19]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,10,19]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2022.13550","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,19]]},"article-number":"430"}}